1 Monoclonal Antibodies Market Overview
1.1 Product Overview and Scope of Monoclonal Antibodies
1.2 Monoclonal Antibodies Segment by Type
1.2.1 Global Monoclonal Antibodies Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Cancer
1.2.3 Autoimmune Diseases
1.2.4 Infection
1.2.5 Hematological Diseases
1.2.6 Others
1.3 Monoclonal Antibodies Segment by Application
1.3.1 Monoclonal Antibodies Sales Comparison by Application: 2020 VS 2026
1.3.2 Oncology
1.3.3 Autoimmune and inflammatory diseases
1.3.4 Respiratory diseases
1.3.5 Ophthalmology
1.4 Global Monoclonal Antibodies Market Size Estimates and Forecasts
1.4.1 Global Monoclonal Antibodies Revenue 2015-2026
1.4.2 Global Monoclonal Antibodies Sales 2015-2026
1.4.3 Monoclonal Antibodies Market Size by Region: 2020 Versus 2026
2 Global Monoclonal Antibodies Market Competition by Manufacturers
2.1 Global Monoclonal Antibodies Sales Market Share by Manufacturers (2015-2020)
2.2 Global Monoclonal Antibodies Revenue Share by Manufacturers (2015-2020)
2.3 Global Monoclonal Antibodies Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Monoclonal Antibodies Manufacturing Sites, Area Served, Product Type
2.5 Monoclonal Antibodies Market Competitive Situation and Trends
2.5.1 Monoclonal Antibodies Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Monoclonal Antibodies Players (Opinion Leaders)
3 Monoclonal Antibodies Retrospective Market Scenario by Region
3.1 Global Monoclonal Antibodies Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Monoclonal Antibodies Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Monoclonal Antibodies Market Facts & Figures by Country
3.3.1 North America Monoclonal Antibodies Sales by Country
3.3.2 North America Monoclonal Antibodies Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Monoclonal Antibodies Market Facts & Figures by Country
3.4.1 Europe Monoclonal Antibodies Sales by Country
3.4.2 Europe Monoclonal Antibodies Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Monoclonal Antibodies Market Facts & Figures by Region
3.5.1 Asia Pacific Monoclonal Antibodies Sales by Region
3.5.2 Asia Pacific Monoclonal Antibodies Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan, China
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Monoclonal Antibodies Market Facts & Figures by Country
3.6.1 Latin America Monoclonal Antibodies Sales by Country
3.6.2 Latin America Monoclonal Antibodies Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Monoclonal Antibodies Market Facts & Figures by Country
3.7.1 Middle East and Africa Monoclonal Antibodies Sales by Country
3.7.2 Middle East and Africa Monoclonal Antibodies Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Monoclonal Antibodies Historic Market Analysis by Type
4.1 Global Monoclonal Antibodies Sales Market Share by Type (2015-2020)
4.2 Global Monoclonal Antibodies Revenue Market Share by Type (2015-2020)
4.3 Global Monoclonal Antibodies Price Market Share by Type (2015-2020)
4.4 Global Monoclonal Antibodies Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Monoclonal Antibodies Historic Market Analysis by Application
5.1 Global Monoclonal Antibodies Sales Market Share by Application (2015-2020)
5.2 Global Monoclonal Antibodies Revenue Market Share by Application (2015-2020)
5.3 Global Monoclonal Antibodies Price by Application (2015-2020)
6 Company Profiles and Key Figures in Monoclonal Antibodies Business
6.1 Company 1
6.1.1 Corporation Information
6.1.2 Company 1 Description, Business Overview and Total Revenue
6.1.3 Company 1 Monoclonal Antibodies Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Company 1 Products Offered
6.1.5 Company 1 Recent Development
6.2 Company 2
6.2.1 Company 2 Monoclonal Antibodies Production Sites and Area Served
6.2.2 Company 2 Description, Business Overview and Total Revenue
6.2.3 Company 2 Monoclonal Antibodies Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Company 2 Products Offered
6.2.5 Company 2 Recent Development
6.3 Company 3
6.3.1 Company 3 Monoclonal Antibodies Production Sites and Area Served
6.3.2 Company 3 Description, Business Overview and Total Revenue
6.3.3 Company 3 Monoclonal Antibodies Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Company 3 Products Offered
6.3.5 Company 3 Recent Development
6.4 Company 4
6.4.1 Company 4 Monoclonal Antibodies Production Sites and Area Served
6.4.2 Company 4 Description, Business Overview and Total Revenue
6.4.3 Company 4 Monoclonal Antibodies Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Company 4 Products Offered
6.4.5 Company 4 Recent Development
6.5 Company 5
6.5.1 Company 5 Monoclonal Antibodies Production Sites and Area Served
6.5.2 Company 5 Description, Business Overview and Total Revenue
6.5.3 Company 5 Monoclonal Antibodies Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Company 5 Products Offered
6.5.5 Company 5 Recent Development
6.6 Company 6
6.6.1 Company 6 Monoclonal Antibodies Production Sites and Area Served
6.6.2 Company 6 Description, Business Overview and Total Revenue
6.6.3 Company 6 Monoclonal Antibodies Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Company 6 Products Offered
6.6.5 Company 6 Recent Development
6.7 Company 7
6.6.1 Company 7 Monoclonal Antibodies Production Sites and Area Served
6.6.2 Company 7 Description, Business Overview and Total Revenue
6.6.3 Company 7 Monoclonal Antibodies Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Company 7 Products Offered
6.7.5 Company 7 Recent Development
6.8 Company 8
6.8.1 Formation Biologionoclonal Antibodies Production Sites and Area Served
6.8.2 Company 8 Description, Business Overview and Total Revenue
6.8.3 Formation Biologionoclonal Antibodies Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Company 8 Products Offered
6.8.5 Company 8 Recent Development
6.9 Company 9
6.9.1 Company 9 Monoclonal Antibodies Production Sites and Area Served
6.9.2 Company 9 Description, Business Overview and Total Revenue
6.9.3 Company 9 Monoclonal Antibodies Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Company 9 Products Offered
6.9.5 Company 9 Recent Development
6.10 Company 10
6.10.1 Company 10 Monoclonal Antibodies Production Sites and Area Served
6.10.2 Company 10 Description, Business Overview and Total Revenue
6.10.3 Company 10 Monoclonal Antibodies Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Company 10 Products Offered
6.10.5 Company 10 Recent Development
6.11 Company 11
6.11.1 Company 11 Monoclonal Antibodies Production Sites and Area Served
6.11.2 Company 11 Monoclonal Antibodies Description, Business Overview and Total Revenue
6.11.3 Company 11 Monoclonal Antibodies Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Company 11 Products Offered
6.11.5 Company 11 Recent Development
6.12 Company 12
6.12.1 Company 12 Monoclonal Antibodies Production Sites and Area Served
6.12.2 Company 12 Monoclonal Antibodies Description, Business Overview and Total Revenue
6.12.3 Company 12 Monoclonal Antibodies Sales, Revenue and Gross Margin (2015-2020)
6.12.4 Company 12 Products Offered
6.12.5 Company 12 Recent Development
6.13 Company 13
6.13.1 Company 13 Monoclonal Antibodies Production Sites and Area Served
6.13.2 Company 13 Monoclonal Antibodies Description, Business Overview and Total Revenue
6.13.3 Company 13 Monoclonal Antibodies Sales, Revenue and Gross Margin (2015-2020)
6.13.4 Company 13 Products Offered
6.13.5 Company 13 Recent Development
6.14 Company 14
6.14.1 Company 14 Monoclonal Antibodies Production Sites and Area Served
6.14.2 Company 14 Monoclonal Antibodies Description, Business Overview and Total Revenue
二〇二〇年至2026年全球單克隆抗體產(chǎn)業(yè)分析及趨勢(shì)預(yù)測(cè)報(bào)告
6.14.3 Company 14 Monoclonal Antibodies Sales, Revenue and Gross Margin (2015-2020)
6.14.4 Company 14 Products Offered
6.14.5 Company 14 Recent Development
6.15 Company 15
6.15.1 Company 15 Monoclonal Antibodies Production Sites and Area Served
6.15.2 Company 15 Monoclonal Antibodies Description, Business Overview and Total Revenue
6.15.3 Company 15 Monoclonal Antibodies Sales, Revenue and Gross Margin (2015-2020)
6.15.4 Company 15 Products Offered
6.15.5 Company 15 Recent Development
6.16 Company 16
6.16.1 Seattle Genetionoclonal Antibodies Production Sites and Area Served
6.16.2 Seattle Genetionoclonal Antibodies Description, Business Overview and Total Revenue
6.16.3 Seattle Genetionoclonal Antibodies Sales, Revenue and Gross Margin (2015-2020)
6.16.4 Company 16 Products Offered
6.16.5 Company 16 Recent Development
6.17 Company 17
6.17.1 Company 17 Monoclonal Antibodies Production Sites and Area Served
6.17.2 Company 17 Monoclonal Antibodies Description, Business Overview and Total Revenue
6.17.3 Company 17 Monoclonal Antibodies Sales, Revenue and Gross Margin (2015-2020)
6.17.4 Company 17 Products Offered
6.17.5 Company 17 Recent Development
6.18 Company 18
6.18.1 Company 18 Monoclonal Antibodies Production Sites and Area Served
6.18.2 Company 18 Monoclonal Antibodies Description, Business Overview and Total Revenue
6.18.3 Company 18 Monoclonal Antibodies Sales, Revenue and Gross Margin (2015-2020)
6.18.4 Company 18 Products Offered
6.18.5 Company 18 Recent Development
6.19 Company 19
6.19.1 Company 19 Monoclonal Antibodies Production Sites and Area Served
6.19.2 Company 19 Monoclonal Antibodies Description, Business Overview and Total Revenue
6.19.3 Company 19 Monoclonal Antibodies Sales, Revenue and Gross Margin (2015-2020)
6.19.4 Company 19 Products Offered
6.19.5 Company 19 Recent Development
6.20 Company 20
6.20.1 Company 20 Monoclonal Antibodies Production Sites and Area Served
6.20.2 Company 20 Monoclonal Antibodies Description, Business Overview and Total Revenue
6.20.3 Company 20 Monoclonal Antibodies Sales, Revenue and Gross Margin (2015-2020)
6.20.4 Company 20 Products Offered
6.20.5 Company 20 Recent Development
7 Monoclonal Antibodies Manufacturing Cost Analysis
7.1 Monoclonal Antibodies Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Monoclonal Antibodies
7.4 Monoclonal Antibodies Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Monoclonal Antibodies Distributors List
8.3 Monoclonal Antibodies Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Monoclonal Antibodies Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Monoclonal Antibodies by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Monoclonal Antibodies by Type (2021-2026)
10.2 Monoclonal Antibodies Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Monoclonal Antibodies by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Monoclonal Antibodies by Application (2021-2026)
10.3 Monoclonal Antibodies Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Monoclonal Antibodies by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Monoclonal Antibodies by Region (2021-2026)
10.4 North America Monoclonal Antibodies Estimates and Projections (2021-2026)
10.5 Europe Monoclonal Antibodies Estimates and Projections (2021-2026)
10.6 Asia Pacific Monoclonal Antibodies Estimates and Projections (2021-2026)
10.7 Latin America Monoclonal Antibodies Estimates and Projections (2021-2026)
10.8 Middle East and Africa Monoclonal Antibodies Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Monoclonal Antibodies Sales (Kg) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Monoclonal Antibodies Sales (Kg) Comparison by Application: 2020 VS 2026
Table 3. Global Monoclonal Antibodies Market Size by Type (Kg) (US$ Million) (2020 VS 2026)
Table 4. Global Key Monoclonal Antibodies Manufacturers Covered in This Study
Table 5. Global Monoclonal Antibodies Sales (Kg) by Manufacturers (2015-2020)
Table 6. Global Monoclonal Antibodies Sales Share by Manufacturers (2015-2020)
Table 7. Global Monoclonal Antibodies Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Monoclonal Antibodies Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Monoclonal Antibodies Average Price (USD/Kg) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Monoclonal Antibodies Sales Sites and Area Served
Table 11. Manufacturers Monoclonal Antibodies Product Types
Table 12. Global Monoclonal Antibodies Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Monoclonal Antibodies by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Monoclonal Antibodies as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Monoclonal Antibodies Players
Table 16. Global Monoclonal Antibodies Sales (Kg) by Region (2015-2020)
Table 17. Global Monoclonal Antibodies Sales Market Share by Region (2015-2020)
Table 18. Global Monoclonal Antibodies Revenue (Million US$) by Region (2015-2020)
Table 19. Global Monoclonal Antibodies Revenue Market Share by Region (2015-2020)
Table 20. North America Monoclonal Antibodies Sales by Country (2015-2020) (Kg)
Table 21. North America Monoclonal Antibodies Sales Market Share by Country (2015-2020)
Table 22. North America Monoclonal Antibodies Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Monoclonal Antibodies Revenue Market Share by Country (2015-2020)
Table 24. Europe Monoclonal Antibodies Sales by Country (2015-2020) (Kg)
Table 25. Europe Monoclonal Antibodies Sales Market Share by Country (2015-2020)
Table 26. Europe Monoclonal Antibodies Revenue by Country (2015-2020) (US$ Million)
二〇二〇年至2026年全球單克隆抗體產(chǎn)業(yè)分析及趨勢(shì)預(yù)測(cè)報(bào)告
Table 27. Europe Monoclonal Antibodies Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Monoclonal Antibodies Sales by Region (2015-2020) (Kg)
Table 29. Asia Pacific Monoclonal Antibodies Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Monoclonal Antibodies Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Monoclonal Antibodies Revenue Market Share by Region (2015-2020)
Table 32. Latin America Monoclonal Antibodies Sales by Country (2015-2020) (Kg)
Table 33. Latin America Monoclonal Antibodies Sales Market Share by Country (2015-2020)
Table 34. Latin America Monoclonal Antibodies Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Monoclonal Antibodies Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Monoclonal Antibodies Sales by Country (2015-2020) (Kg)
Table 37. Middle East and Africa Monoclonal Antibodies Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Monoclonal Antibodies Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Monoclonal Antibodies Revenue Market Share by Country (2015-2020)
Table 40. Global Monoclonal Antibodies Sales (Kg) by Type (2015-2020)
Table 41. Global Monoclonal Antibodies Sales Share by Type (2015-2020)
Table 42. Global Monoclonal Antibodies Revenue (Million US$) by Type (2015-2020)
Table 43. Global Monoclonal Antibodies Revenue Share by Type (2015-2020)
Table 44. Global Monoclonal Antibodies Price (USD/Kg) by Type (2015-2020)
Table 45. Global Monoclonal Antibodies Sales (Kg) by Application (2015-2020)
Table 46. Global Monoclonal Antibodies Sales Market Share by Application (2015-2020)
Table 47. Global Monoclonal Antibodies Sales Growth Rate by Application (2015-2020)
Table 48. Company 1 Monoclonal Antibodies Corporation Information
Table 49. Company 1 Description and Business Overview
Table 50. Company 1 Monoclonal Antibodies Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 51. Company 1 Main Product
Table 52. Company 1 Recent Development
Table 53. Company 2 Monoclonal Antibodies Corporation Information
Table 54. Company 2 Corporation Information
Table 55. Company 2 Monoclonal Antibodies Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 56. Company 2 Main Product
Table 57. Company 2 Recent Development
Table 58. Company 3 Monoclonal Antibodies Corporation Information
Table 59. Company 3 Corporation Information
Table 60. Company 3 Monoclonal Antibodies Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 61. Company 3 Main Product
Table 62. Company 3 Recent Development
Table 63. Company 4 Monoclonal Antibodies Corporation Information
Table 64. Company 4 Corporation Information
Table 65. Company 4 Monoclonal Antibodies Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 66. Company 4 Main Product
Table 67. Company 4 Recent Development
Table 68. Company 5 Monoclonal Antibodies Corporation Information
Table 69. Company 5 Corporation Information
Table 70. Company 5 Monoclonal Antibodies Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 71. Company 5 Main Product
Table 72. Company 5 Recent Development
Table 73. Company 6 Monoclonal Antibodies Corporation Information
Table 74. Company 6 Corporation Information
Table 75. Company 6 Monoclonal Antibodies Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 76. Company 6 Main Product
Table 77. Company 6 Recent Development
Table 78. Company 7 Monoclonal Antibodies Corporation Information
Table 79. Company 7 Corporation Information
Table 80. Company 7 Monoclonal Antibodies Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 81. Company 7 Main Product
Table 82. Company 7 Recent Development
Table 83. Formation Biologionoclonal Antibodies Corporation Information
Table 84. Company 8 Corporation Information
Table 85. Formation Biologionoclonal Antibodies Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 86. Formation Biologiain Product
Table 87. Company 8 Recent Development
Table 88. Company 9 Monoclonal Antibodies Corporation Information
Table 89. Company 9 Corporation Information
Table 90. Company 9 Monoclonal Antibodies Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 91. Company 9 Main Product
Table 92. Company 9 Recent Development
Table 93. Company 10 Monoclonal Antibodies Corporation Information
Table 94. Company 10 Corporation Information
Table 95. Company 10 Monoclonal Antibodies Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 96. Company 10 Main Product
Table 97. Company 10 Recent Development
Table 98. Company 11 Monoclonal Antibodies Corporation Information
Table 99. Company 11 Corporation Information
Table 100. Company 11 Monoclonal Antibodies Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 101. Company 11 Main Product
Table 102. Company 11 Recent Development
Table 103. Company 12 Monoclonal Antibodies Corporation Information
Table 104. Company 12 Corporation Information
Table 105. Company 12 Monoclonal Antibodies Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 106. Company 12 Main Product
Table 107. Company 12 Recent Development
Table 108. Company 13 Monoclonal Antibodies Corporation Information
Table 109. Company 13 Corporation Information
Table 110. Company 13 Monoclonal Antibodies Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 111. Company 13 Main Product
Table 112. Company 13 Recent Development
Table 113. Company 14 Monoclonal Antibodies Corporation Information
Table 114. Company 14 Corporation Information
Table 115. Company 14 Monoclonal Antibodies Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 116. Company 14 Main Product
Table 117. Company 14 Recent Development
Table 118. Company 15 Monoclonal Antibodies Corporation Information
Table 119. Company 15 Corporation Information
Table 120. Company 15 Monoclonal Antibodies Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 121. Company 15 Main Product
Table 122. Company 15 Recent Development
Table 123. Seattle Genetionoclonal Antibodies Corporation Information
Table 124. Company 16 Corporation Information
Table 125. Seattle Genetionoclonal Antibodies Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 126. Seattle Genetiain Product
Table 127. Company 16 Recent Development
Table 128. Company 17 Monoclonal Antibodies Corporation Information
Table 129. Company 17 Corporation Information
Table 130. Company 17 Monoclonal Antibodies Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 131. Company 17 Main Product
Table 132. Company 17 Recent Development
Table 133. Company 18 Monoclonal Antibodies Corporation Information
Table 134. Company 18 Corporation Information
Table 135. Company 18 Monoclonal Antibodies Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
èr líng èr líng nián zhì 2026 nián quánqiú dān kèlóng kàngtǐ chǎnyè fēnxī jí qūshì yùcè bàogào
Table 136. Company 18 Main Product
Table 137. Company 18 Recent Development
Table 138. Company 19 Monoclonal Antibodies Corporation Information
Table 139. Company 19 Corporation Information
Table 140. Company 19 Monoclonal Antibodies Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 141. Company 19 Main Product
Table 142. Company 19 Recent Development
Table 143. Company 20 Monoclonal Antibodies Corporation Information
Table 144. Company 20 Corporation Information
Table 145. Company 20 Monoclonal Antibodies Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 146. Company 20 Main Product
Table 147. Company 20 Recent Development
Table 148. Sales Base and Market Concentration Rate of Raw Material
Table 149. Key Suppliers of Raw Materials
Table 150. Monoclonal Antibodies Distributors List
Table 151. Monoclonal Antibodies Customers List
Table 152. Market Key Trends
Table 153. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 154. Key Challenges
Table 155. Global Monoclonal Antibodies Sales (Kg) Forecast by Type (2021-2026)
Table 156. Global Monoclonal Antibodies Sales Market Share Forecast by Type (2021-2026)
Table 157. Global Monoclonal Antibodies Revenue (Million US$) Forecast by Type (2021-2026)
Table 158. Global Monoclonal Antibodies Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 159. Global Monoclonal Antibodies Sales (Kg) Forecast by Application (2021-2026)
Table 160. Global Monoclonal Antibodies Revenue (Million US$) Forecast by Application (2021-2026)
Table 161. Global Monoclonal Antibodies Sales (Kg) Forecast by Region (2021-2026)
Table 162. Global Monoclonal Antibodies Sales Market Share Forecast by Region (2021-2026)
Table 163. Global Monoclonal Antibodies Revenue Forecast by Region (2021-2026) (US$ Million)
Table 164. Global Monoclonal Antibodies Revenue Market Share Forecast by Region (2021-2026)
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Monoclonal Antibodies
Figure 2. Global Monoclonal Antibodies Sales Market Share by Type: 2020 VS 2026
Figure 3. Cancer Product Picture
Figure 4. Autoimmune Diseases Product Picture
Figure 5. Infection Product Picture
Figure 6. Hematological Diseases Product Picture
Figure 7. Others Product Picture
Figure 8. Global Monoclonal Antibodies Consumption Market Share by Application: 2020 VS 2026
Figure 9. Oncology
Figure 10. Autoimmune and inflammatory diseases
Figure 11. Respiratory diseases
Figure 12. Ophthalmology
Figure 13. Global Monoclonal Antibodies Market Size 2015-2026 (US$ Million)
Figure 14. Global Monoclonal Antibodies Sales Capacity (Kg) (2015-2026)
Figure 15. Global Monoclonal Antibodies Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Monoclonal Antibodies Sales Share by Manufacturers in 2020
Figure 17. Global Monoclonal Antibodies Revenue Share by Manufacturers in 2019
Figure 18. The Global 5 and 10 Largest Players: Market Share by Monoclonal Antibodies Revenue in 2019
Figure 19. Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Monoclonal Antibodies Sales Market Share by Region (2015-2020)
Figure 21. Global Monoclonal Antibodies Sales Market Share by Region in 2019
Figure 22. Global Monoclonal Antibodies Revenue Market Share by Region (2015-2020)
Figure 23. Global Monoclonal Antibodies Revenue Market Share by Region in 2019
Figure 24. North America Monoclonal Antibodies Sales Market Share by Country in 2019
Figure 25. North America Monoclonal Antibodies Revenue Market Share by Country in 2019
Figure 26. U.S. Monoclonal Antibodies Sales Growth Rate (2015-2020) (Kg)
Figure 27. U.S. Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 28. Canada Monoclonal Antibodies Sales Growth Rate (2015-2020) (Kg)
Figure 29. Canada Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 30. Europe Monoclonal Antibodies Sales Market Share by Country in 2019
Figure 31. Europe Monoclonal Antibodies Revenue Market Share by Country in 2019
Figure 32. Germany Monoclonal Antibodies Sales Growth Rate (2015-2020) (Kg)
Figure 33. Germany Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. France Monoclonal Antibodies Sales Growth Rate (2015-2020) (Kg)
Figure 35. France Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. U.K. Monoclonal Antibodies Sales Growth Rate (2015-2020) (Kg)
Figure 37. U.K. Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Italy Monoclonal Antibodies Sales Growth Rate (2015-2020) (Kg)
Figure 39. Italy Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Russia Monoclonal Antibodies Sales Growth Rate (2015-2020) (Kg)
Figure 41. Russia Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Asia Pacific Monoclonal Antibodies Sales Market Share by Region in 2019
Figure 43. Asia Pacific Monoclonal Antibodies Revenue Market Share by Region in 2019
Figure 44. China Monoclonal Antibodies Sales Growth Rate (2015-2020) (Kg)
Figure 45. China Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. Japan Monoclonal Antibodies Sales Growth Rate (2015-2020) (Kg)
Figure 47. Japan Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. South Korea Monoclonal Antibodies Sales Growth Rate (2015-2020) (Kg)
Figure 49. South Korea Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. India Monoclonal Antibodies Sales Growth Rate (2015-2020) (Kg)
Figure 51. India Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Australia Monoclonal Antibodies Sales Growth Rate (2015-2020) (Kg)
Figure 53. Australia Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Taiwan, China Monoclonal Antibodies Sales Growth Rate (2015-2020) (Kg)
Figure 55. Taiwan, China Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Indonesia Monoclonal Antibodies Sales Growth Rate (2015-2020) (Kg)
Figure 57. Indonesia Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Thailand Monoclonal Antibodies Sales Growth Rate (2015-2020) (Kg)
Figure 59. Thailand Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Malaysia Monoclonal Antibodies Sales Growth Rate (2015-2020) (Kg)
Figure 61. Malaysia Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Philippines Monoclonal Antibodies Sales Growth Rate (2015-2020) (Kg)
Figure 63. Philippines Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Vietnam Monoclonal Antibodies Sales Growth Rate (2015-2020) (Kg)
Figure 65. Vietnam Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Latin America Monoclonal Antibodies Sales Market Share by Country in 2019
Figure 67. Latin America Monoclonal Antibodies Revenue Market Share by Country in 2019
Figure 68. Mexico Monoclonal Antibodies Sales Growth Rate (2015-2020) (Kg)
Figure 69. Mexico Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Brazil Monoclonal Antibodies Sales Growth Rate (2015-2020) (Kg)
Figure 71. Brazil Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Argentina Monoclonal Antibodies Sales Growth Rate (2015-2020) (Kg)
2020-2026グローバルモノクローナル抗體業(yè)界分析とトレンド予測(cè)レポート
Figure 73. Argentina Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Middle East and Africa Monoclonal Antibodies Sales Market Share by Country in 2019
Figure 75. Middle East and Africa Monoclonal Antibodies Revenue Market Share by Country in 2019
Figure 76. Turkey Monoclonal Antibodies Sales Growth Rate (2015-2020) (Kg)
Figure 77. Turkey Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Saudi Arabia Monoclonal Antibodies Sales Growth Rate (2015-2020) (Kg)
Figure 79. Saudi Arabia Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. U.A.E Monoclonal Antibodies Sales Growth Rate (2015-2020) (Kg)
Figure 81. U.A.E Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Sales Market Share of Monoclonal Antibodies by Type (2015-2020)
Figure 83. Sales Market Share of Monoclonal Antibodies by Type in 2019
Figure 84. Revenue Share of Monoclonal Antibodies by Type (2015-2020)
Figure 85. Revenue Market Share of Monoclonal Antibodies by Type in 2019
Figure 86. Global Monoclonal Antibodies Sales Growth by Type (2015-2020) (Kg)
Figure 87. Global Monoclonal Antibodies Sales Market Share by Application (2015-2020)
Figure 88. Global Monoclonal Antibodies Sales Market Share by Application in 2019
Figure 89. Global Revenue Share of Monoclonal Antibodies by Application (2015-2020)
Figure 90. Global Revenue Share of Monoclonal Antibodies by Application in 2020
Figure 91. Company 1 Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Company 2 Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Company 3 Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Company 4 Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Company 5 Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Company 6 Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Company 7 Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Company 8 Total Revenue (US$ Million): 2019 Compared with 2018
Figure 99. Company 9 Total Revenue (US$ Million): 2019 Compared with 2018
Figure 100. Company 10 Total Revenue (US$ Million): 2019 Compared with 2018
Figure 101. Company 11 Total Revenue (US$ Million): 2019 Compared with 2018
Figure 102. Company 12 Total Revenue (US$ Million): 2019 Compared with 2018
Figure 103. Company 13 Total Revenue (US$ Million): 2019 Compared with 2018
Figure 104. Company 14 Total Revenue (US$ Million): 2019 Compared with 2018
Figure 105. Company 15 Total Revenue (US$ Million): 2019 Compared with 2018
Figure 106. Company 16 Total Revenue (US$ Million): 2019 Compared with 2018
Figure 107. Company 17 Total Revenue (US$ Million): 2019 Compared with 2018
Figure 108. Company 18 Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Company 19 Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Company 20 Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Price Trend of Key Raw Materials
Figure 112. Manufacturing Cost Structure of Monoclonal Antibodies
Figure 113. Manufacturing Process Analysis of Monoclonal Antibodies
Figure 114. Monoclonal Antibodies Industrial Chain Analysis
Figure 115. Channels of Distribution
Figure 116. Distributors Profiles
Figure 117. Porter's Five Forces Analysis
Figure 118. North America Monoclonal Antibodies Sales (Kg) and Growth Rate Forecast (2021-2026)
Figure 119. North America Monoclonal Antibodies Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 120. Europe Monoclonal Antibodies Sales (Kg) and Growth Rate Forecast (2021-2026)
Figure 121. Europe Monoclonal Antibodies Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 122. Latin America Monoclonal Antibodies Sales (Kg) and Growth Rate Forecast (2021-2026)
Figure 123. Latin America Monoclonal Antibodies Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 124. Middle East and Africa Monoclonal Antibodies Sales (Kg) and Growth Rate Forecast (2021-2026)
Figure 125. Middle East and Africa Monoclonal Antibodies Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 126. Asia Pacific Monoclonal Antibodies Sales (Kg) and Growth Rate Forecast (2021-2026)
Figure 127. Asia Pacific Monoclonal Antibodies Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 128. Bottom-up and Top-down Approaches for This Report
Figure 129. Data Triangulation
Figure 130. Key Executives Interviewed
……
請(qǐng)您致電：400 612 8668、010-6618 1099、66182099、66183099
或Email至：KF@Cir.cn 【網(wǎng)上訂購(gòu)】 ┊ 下載《訂購(gòu)協(xié)議》 ┊ 了解“訂購(gòu)流程”
京公網(wǎng)安備 11010802027365號(hào)